Midwest Professional Planners, Ltd. Eli Lilly & CO Transaction History

Midwest Professional Planners, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $45,946 - $61,436	-131 Reduced 18.77%	567 $265,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $7,074 - $8,242	-22 Reduced 3.06%	698 $255,000
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 2.56%	720 $233,000
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $278 - $327	-1 Reduced 0.14%	702 $228,000
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $164,987 - $205,036	703 New	703 $201,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $26,616 - $33,266	-310 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $757 - $868	10 Added 3.33%	310 $26,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $2,448 - $2,890	33 Added 12.36%	300 $23,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $21,877 - $23,466	267	267 $23,000

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.